1.75
price up icon2.94%   0.05
after-market アフターアワーズ: 1.70 -0.05 -2.86%
loading
前日終値:
$1.70
開ける:
$1.72
24時間の取引高:
46,471
Relative Volume:
0.22
時価総額:
$10.24M
収益:
$2.35M
当期純損益:
$-2.56M
株価収益率:
-3.9054
EPS:
-0.4481
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-6.42%
1か月 パフォーマンス:
-4.61%
6か月 パフォーマンス:
-14.63%
1年 パフォーマンス:
-32.16%
1日の値動き範囲:
Value
$1.7006
$1.80
1週間の範囲:
Value
$1.60
$1.94
52週間の値動き範囲:
Value
$1.50
$2.87

Immuron Limited Adr Stock (IMRN) Company Profile

Name
名前
Immuron Limited Adr
Name
セクター
Healthcare (1163)
Name
電話
-
Name
住所
-
Name
職員
7
Name
Twitter
@ImmuronLtd
Name
次回の収益日
2024-08-27
Name
最新のSEC提出書
Name
IMRN's Discussions on Twitter

IMRN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IMRN
Immuron Limited Adr
1.75 9.74M 2.35M -2.56M 0 -0.4481
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Immuron Limited Adr (IMRN) 最新ニュース

pulisher
Jul 19, 2025

What drives Immuron Limited Depositary Receipt stock priceHigh-yield capital appreciation - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 17, 2025

Immuron - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 04, 2025

immuron ltd files for quotation of securities on ASX - Investing.com

Jun 04, 2025
pulisher
May 30, 2025

Immuron Letter to Shareholders: Projects Update - GlobeNewswire Inc.

May 30, 2025
pulisher
May 04, 2025

IMRNImmuron Ltd Latest Stock News & Market Updates - Stock Titan

May 04, 2025
pulisher
Mar 05, 2025

Immuron and Calmino join up to treat Irritable Bowel Syndrome (IBS) - Markets Insider

Mar 05, 2025
pulisher
Jan 30, 2025

Immuron: Targeted oral antibodies to treat infectious diseases - Innovation News Network

Jan 30, 2025
pulisher
Oct 04, 2024

NMRC Reports Results for Campylobacter Controlled Human Infection Model Study - GlobeNewswire

Oct 04, 2024
pulisher
Sep 05, 2024

Immuron Plans Phase 2 Trial for IMM-529 following FDA review - FinancialContent

Sep 05, 2024
pulisher
Jul 02, 2024

Immuron requests pre-IND meeting for IMM-529 with FDA filing - GlobeNewswire

Jul 02, 2024
pulisher
Apr 10, 2024

Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Markets Insider

Apr 10, 2024
pulisher
Mar 07, 2024

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.34% - Investing.com UK

Mar 07, 2024
pulisher
Jul 26, 2022

Immuron US DoD Naval Medical Research Center Receives feedback on IND Application for New Campylobacter ETEC Therapeutic - StockTitan

Jul 26, 2022
pulisher
Jan 19, 2022

Immuron LimitedADR Shares Close the Week 61.5% HigherWeekly Wrap - Nasdaq

Jan 19, 2022
pulisher
Jun 27, 2018

Immuron Limited Trade Ideas — NASDAQ:IMRN - TradingView

Jun 27, 2018
pulisher
Jun 07, 2018

IMC Reports Rising Revenues & Eyes Colitis Market - Next Investors

Jun 07, 2018
pulisher
Jul 19, 2017

IMC Stock Price and Chart — ASX:IMC - TradingView

Jul 19, 2017

Immuron Limited Adr (IMRN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
大文字化:     |  ボリューム (24 時間):